Skip to main content
OpenTrials
Completed

NCT Number: NCT03146429

Prediction of Future Weight Change With Dopamine Transporter

This is the re-analyzing study of observational study by Parkinson's Progression Markers Initiative

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Weight Change, Body Body Weight Body Weight Changes Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

30 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • males or females with their age of 30 years or older at screening

Exclusion criteria

  • subjects with a neurological disorder, a first degree relative with idiopathic PD, Montreal Cognitive Assessment score of 26 or less, medications that might interfere with DAT SPECT scans, anticoagulants that might preclude safe completion of the lumbar puncture, or investigational drugs, and a condition that precludes the safe performance of routine lumbar puncture

Treatment and study plan

I-123 FP-CIT Single photon emission tomography

Diagnostic Test

Brain scan for dopamine transporter

Primary outcomes

  1. Weight change

    Time frame: 1, 2, 3, 4, 5 year after SPECT

    weight change per year until 5 years after SPECT

Sponsors and collaborators

Lead sponsor

Pusan National University Hospital

Other

Registry information

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
May 10, 2017
Registry last updated
Apr 24, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.